Latest Opdivo news
AAAAI: No Increase Seen in Asthma Exacerbations With ICI Use for Melanoma, Renal Cell Carcinoma
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma
posted October 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
posted February 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Study IDs Gaps in Hereditary Breast Cancer Risk Assessment Before Gender-Affirming Mastectomy 
Family History Drives Cancer Risk in BRCA Test Groups 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Global Findings Indicate Breast Cancer and A-Fib Incidence Frequently Overlap 
Entinostat + Nivolumab Yields Durable Results in Some Pancreatic Cancer Patients 
Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma 
Adjuvant Nivolumab Slows Muscle-Invasive Urothelial Carcinoma Monthly Specialist Briefings
Stay Connected
